CancerX shared on LinkedIn:
“Three years of impact. Global representation. 42 companies with results.
Since launching in 2024, the CancerX Accelerator, a 6-month program, has become the launchpad for oncology innovation.
Startups in our cohorts have raised an average of $42 million, and each year we see our cohort companies with at least one concrete opportunity in motion: a paid pilot, a signed contract, or a collaboration.
If you’re building in oncology, don’t miss your chance to be part of the growth story.
Why apply:
- Champions ready to engage with you before you’re accepted. No startup joins until at least two Champion organizations sponsor them in the cohort.
- Zero equity, no fees. Just six months of invite-only events and access to experts, targeted curriculum, and a vetted expert mentor network.
- Real results. In our graduating class, every startup generated 1 to 3 deal opportunities.
Apply now by signing into your Constellation account: 2027 Accelerator Themes.”
Other articles about CancerX on OncoDaily.